|
|
Ladies and Lipids: Cardiovascular Risk Across the Lifespan
Recorded for 2025 National Conference
|
|
Facebook
LinkedIn
E-Mail
|
(84)
Category: 2025 National Conference, Cardiology, Cardiometabolic, Cardiovascular, Cert Exam Domain - Assessment, Cert Exam Domain - Evaluation, Health Equities, Health Promotion, Lipids, Recent Additions, Women's Health (show less)
|
Activity Duration| Content Expires: | July 15, 2026 (11:55 p.m. CT)
CE for this activity will not be available after this date. |
This CE activity was recorded for the 2025 AANP National Conference.  | This activity includes closed captioning. |
| Delivery Note: The content for this activity was previously presented during the 2025 AANP National Conference. If you already completed the content of this activity while attending the live or virtual conference, you should not complete this content a second time. Learners should only complete ONE delivery-method to earn credit. Completing multiple delivery options for the same activity is considered duplicate credit for the same content and will not be accepted by regulatory bodies. |
Overview
This session is to enhance clinical practice in cardiovascular/cardiometabolic health of women across the lifespan. Women's cardiovascular rates are increasing among younger women <55 years as well as an increase of suboptimal cardiovascular health during pregnancy. There is increase in metabolic syndrome leading to prevalence of dyslipidemias. Missed or delayed diagnosis with undertreatment of lipids contributes to cardiovascular disease. Younger women are less likely to be treated less and to achieving therapeutic targets. Previous guidelines acknowledge sex-specific risk enhancing factors for lipid management in women for Cardiovascular prevention, however there is a continued need for sex-specific guidelines for evaluation and management of lipids. Lipids are impacted during normal hormonal changes throughout a woman's life cycle- during adolescence, pre-pregnancy, pregnancy, pre- and perimenopause, menopause, and at older ages. Women need to understand their personalized cholesterol goals and ally with their clinicians to ensure appropriate and aggressive therapies are made available to female patients. There will be focus on management of primary prevention of cardiovascular disease by examining sex-specific cardiovascular risk factors at each stage and pay special attention to statin use, statin side effects and non-statin therapies. Future research should focus on increasing enrollment of women in lipid trials.
Objectives
- Evaluate Cardiometabolic risk through Lipids and the changes across a women’s lifespan.
- Address the need for sex-specific guidelines for evaluation and management of lipids across a women's lifespan for Cardiovascular disease prevention.
- Implement evidence driven and guidelines for assessment for early recognition and treatment of Familial Hypercholesterolemia, Lipoprotein (a), and metabolic syndrome.
- Identify common dyslipidemias that should be addressed during pregnancy due to the increased risk for adverse pregnancy outcomes, such as preeclampsia, gestational diabetes mellitus, and pre-term delivery, as well as pancreatitis in the presence of severe hypertriglyceridemia.
Speaker
Caroline deRichemond, CRNP, CLS, FNLA
Disclosure
This program was planned in accordance with AANP CE Standards and Policies.
The speaker has the following disclosures:- Lipid Consultant for Merck Pharmaceutical
All relevant financial relationships have been mitigated.
DisclaimerIndividuals who have contributed to the CE Center (content originally from the 2025 AANP National Conference) were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit Instructions
- Read this activity description, including objectives and disclosures.
- Complete all educational content:
- OnDemand Presentations: Click the Play button to watch the activity video lecture. To get full credit for the learning activity portion, you must watch all of the video content.
- Click on the Additional Resources button to review all additional materials provided (handouts and any other downloadable resources).
- After completing all educational content, go to the Next Steps button:
- Submit the activity evaluation to receive full AANP CE/Rx credit.
- Click on the Get Certificate button. At the top of the certificate screen, use the provided dropdown menu and select AANP Certificate of Completion.
- A copy of your certificate of completion will display on the screen for you to print or save. A copy of the certificate will also be emailed to you.
- A copy of the certificate will be automatically added to your AANP CE Tracker.
Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
0.8 Contact Hour(s) of CE,
0.2 of which may be applied towards Pharmacology
|
|
Additional CE activities of interest
(OnDemand)
Obesity and Menopause: Improving Outcomes
(OnDemand)
Optimizing Midlife Health of Women
(OnDemand)
What To Do First with Type 2 Diabetes
(OnDemand)
Hormones for Vasomotor Symptoms of Menopause: A Primer for the Primary Care Providers
(OnDemand)
Osteoporosis Management and Fracture Prevention
(OnDemand)
Common GI Complaints
(OnDemand)
Obesity: Where Pathophysiology and NP Primary Care Practice Collide
(OnDemand)
Nuts and Bolts of Hypothyroid Disease in Primary Care
(OnDemand)
Cognitive Decline and Diabetes in Older Adults
(OnDemand)
Headaches: Everything but Migraine
(OnDemand)
A Focus on Men’s Health: Erectile Dysfunction and Testosterone Deficiency
(OnDemand)
Cervical Cancer Prevention: An Update on New Screening and Risk-Based Management Guidelines
|
|
Adding Registration, Please wait...
